|
FUJIFILM Biotechnologies is proud to be an innovative CDMO partner, seamlessly guiding our customers though their journey of creating life-impacting medicines from initial process development stages through to full commercial supply. Catch up on our latest news and insights below.
|
|
|
FUJIFILM Biotechnologies was named a winner in the 2026 CDMO Leadership Awards for Most Innovative CDMO (Biologics) at DCAT last month – a recognition driven by verified sponsor feedback. This honor reflects our sustained investment in science, analytics, and process development, including the recent launch of ShunzymeX™, a novel platform simplifying complex biologics purification. FUJIFILM Biotechnologies Chief Operating Officer, Maja Pedersen, also highlighted the investment in innovation as part of her DCAT member company presentation sharing updates on our $8B expansion plan.
Thank you to our partners for your trust and recognition. Our success is driven by collaboration, transparency, and a shared commitment to be Partners for Life.
|
|
|
kojoXTM – Transforming Global Bioproduction
|
|
| Learn more about our kojoX philosophy
|
|
|
| Discover how our modular biomanufacturing approach can future proof your supply chain
|
|
|
| Leverage our kojoX ecosystem to rapidly expand manufacturing capacity in response to surging market demand
|
|
|
- Maja Pedersen, Chief Operating Officer at FUJIFILM Biotechnologies recently sat down with the team at The Pharma Navigator to discuss how modularity, AI-driven compliance, and harmonized global networks are necessary to resolve the complex challenges in downstream processing. Read the full article
- Maja
Pedersen has also been discussing our recent investments and UK expansion projects with the team at Pharma Manufacturing. In this article, Maja highlights how kojoX is now expanding across our entire network. Read the full article
- On April 15th, FUJIFILM Biotechnologies announced the opening of its new, 2,000-square-meter (m2) quality control (QC) laboratory at our Hillerød, Denmark commercial-scale manufacturing site. Learn all about the latest expansion in this Pharma Manufacturing article. Read the full
article
- Toshi Iida, Director, FUJIFILM Corporation and Chairman FUJIFILM Biotechnologies, and Brandon Pence, President and COO of FUJIFILM Biosciences recently sat down for an interview with Endpoints News’ CEO Arsalan Arif to discuss the company’s expanding role in the biopharmaceutical industry. Read the interview transcript
|
|
May 11-15, 2026 | Menino Convention & Exhibition Center, Boston, MA | Booth 1031
|
|
Be sure to connect with our Cell & Gene Therapy team of experts during ASGCT to discuss development and manufacturing needs for your therapy. Join us at booth 1031, attend our symposium presentation on Wednesday, May 13 at 8 AM (Room 109 AB), and drop by our poster sessions to learn more about our CDMO services and solutions.
Learn More →
|
|
|
June 22-25, 2026 | San Diego Convention Center | San Diego, CA | Booth 3123
|
|
Join us at BIO to hear about our latest global expansions and technologies and connect with experts to discuss how we can help advance your program and secure your supply. Visit us at booth #3123 or schedule a partnering meeting today.
Learn More →
|
|
|
FUJIFILM Biotechnologies
101 J Morris Commons Ln Ste 135
Morrisville, North Carolina 27560
|
|
|
|
|
